OraSure Technologies (OSUR) Shares are Down -0.43%

OraSure Technologies (OSUR) has risen sharply, recording gains of 7.43% in the past 4 weeks. However, the stock has corrected -0.43% in the past 1 week, providing a good buying opportunity on dips. On a relative basis, the stock has outperformed the S&P 500 by 7.02% in the past 4 weeks, but has underperformed the S&P 500 in the past 1 week.

OraSure Technologies, Inc. is up 1.46% in the last 3-month period. Year-to-Date the stock performance stands at 7.76%. The stock has recorded a 20-day Moving Average of 0.89% and the 50-Day Moving Average is 2.77%.


OraSure Technologies (NASDAQ:OSUR): During Fridays trading session, Bulls were in full control of the stock right from the opening. The stock opened at $6.91 and $6.84 proved to be the low of the day. Continuous buying at higher levels pushed the stock towards an intraday high of $7.02. The buying momentum continued till the end and the stock did not give up its gains. It closed at $6.94, notching a gain of 0.14% for the day. The total traded volume was 341,854 . The stock had closed at $6.93 on the previous day.

Also, Jefferies maintains its rating on OraSure Technologies (NASDAQ:OSUR). The global brokerage major lowers the current price target from $8.5 per share to $8 per share. Analysts at the Jefferies have a current rating of Buy on the shares. The rating by the firm was issued on August 4, 2016.

OraSure Technologies, Inc. (OraSure) is involved in the development, manufacture, marketing and sale of oral fluid diagnostic products and specimen collection devices and other diagnostic products designed to detect or diagnose critical medical conditions. These products include OraQuick In-Home HIV Test, OraQuick ADVANCE, OraSure HIV-1 oral specimen collection device, OraQuick HCV rapid antibody test, Intercept oral fluid drug testing system, OraSure QuickFlu Rapid Flu A&B Test and Q.E.D. Saliva Alcohol test. The Company also manufactures and sells a range of cryosurgical products. Through its wholly owned subsidiary, DNA Genotek Inc., the Company provides oral fluid sample collection, stabilization and preparation products for molecular diagnostic applications.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *

Get Pre-Market Alerts!

Get Pre-Market Analysts' Upgrades, Downgrades, Earnings & Initiations with our FREE daily email newsletter.